Takeda Pharmaceutical Co Ltd (4502.T) News| Reuters.com
Edition:
United States

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,438JPY
2:00am EDT
Change (% chg)

¥14 (+0.32%)
Prev Close
¥4,424
Open
¥4,426
Day's High
¥4,442
Day's Low
¥4,389
Volume
2,052,300
Avg. Vol
2,696,990
52-wk High
¥6,609
52-wk Low
¥4,098

Select another date:

Thu, Jun 9 2016

Hikma seeks dismissal of Takeda's bid to block gout drug sales

Hikma Pharmaceuticals PLC is asking a federal appeals court to reject a bid by rival Takeda Pharmaceutical Co to halt sales of Hikma's gout drug Mitigare, arguing that the challenge is moot after Hikma won a separate patent case last month.

BRIEF-Takeda, Roivant Sciences launch Myovant Sciences to develop therapeutics for women's health, prostate cancer

* Roivant Sciences and Takeda launch Myovant Sciences to develop therapeutics for women's health and prostate cancer

BRIEF-Takeda Pharmaceutical Co Ltd receives positive CHMP opinion for ADCETRIS

* Takeda receives positive CHMP opinion for ADCETRIS as consolidation treatment in post-transplant hodgkin lymphoma Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Valeant rejected joint takeover bid from Takeda, TPG in spring: source

Valeant Pharmaceuticals International Inc received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd and TPG Capital Management LP [TPG.UL] this spring that the Canadian drugmaker rejected, according to a source familiar with the matter.

UPDATE 2-Valeant rejected joint takeover bid from Takeda, TPG in spring - source

May 26 Valeant Pharmaceuticals International Inc received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd and TPG Capital Management LP this spring that the Canadian drugmaker rejected, according to a source familiar with the matter.

BRIEF-Valeant received joint takeover approach from Takeda, TPG before Joseph Papa became CEO - source

* Valeant received joint takeover approach from Takeda, TPG a few weeks before Joseph Papa became CEO - Source Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Valeant rejected joint takeover bid from Takeda, TPG in spring-WSJ

May 26 Valeant Pharmaceuticals International Inc received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd and TPG Capital Management LP this spring that the Canadian drugmaker rejected, the Wall Street Journal reported, citing people familiar with the matter.

BRIEF-Valeant approached by earlier rejected Takeda, TPG for takeover-CNBC

* Valeant received joint takeover approach from Takeda, TPG that it rejected this spring before hiring new CEO - CNBC, citing DJ

Hikma wins dismissal of Takeda patent lawsuit over gout drug

A federal court has cleared the way for Hikma Pharmaceuticals Plc to continue selling a drug with the same active chemical as Takeda Pharmaceutical Co's gout drug Colcrys, dismissing a patent lawsuit Takeda filed in an effort to keep the drug off the market.

Gates Foundation backs Takeda polio vaccine with $38 million grant

LONDON Japan's Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries.

Select another date: